Metabolic syndrome in early pregnancy and risk of preterm birth

American Journal of Epidemiology

Volumn 170, Issue 7, 2009, Pages 829-836

  Chatzi, Leda ^a   Plana, Estel ^b,c,d   Daraki, Vasiliki ^a   Karakosta, Polyxeni ^a   Alegkakis, Dimitris ^a   Tsatsanis, Christos ^a   Kafatos, Antonis ^a   Koutis, Antonis ^a   Kogevinas, Manolis ^a,c,d  

^a UNIVERSITY OF CRETE   (Greece)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

Author keywords

Fetal growth retardation; Metabolic syndrome X; Premature birth

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

BODY MASS; COHORT ANALYSIS; FASTING; HEALTH RISK; HYPERTENSION; METABOLISM; PREGNANCY; PROTEIN; REGRESSION ANALYSIS; RISK FACTOR; SERUM;

ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FETUS GROWTH; FETUS WEIGHT; FIRST TRIMESTER PREGNANCY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PREMATURE LABOR; RISK FACTOR;

ADULT; CASE-CONTROL STUDIES; FEMALE; FETAL GROWTH RETARDATION; GREECE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREMATURE BIRTH; PROSPECTIVE STUDIES; RISK;

CRETE; EURASIA; EUROPE; GREECE; SOUTHERN EUROPE;

RHEA;

EID: 70349484217     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp211     Document Type: Article

References (34)

1. Grundy SM Cleeman JI Daniels S et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart Lung and Blood Institute scientific statement. Circulation 2005 112:17 (2735-2752). (Pubitemid 41532612)
2. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006; 97(2A):3A-11A.
3. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-867.
4. Wilson PW, Grundy SM. The metabolic syndrome: practical guide to origins and treatment: part I. Circulation. 2003; 108(12):1422-1424.
5. Balkau B, Charles MA, Drivsholm T, et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002;28(5):364-376.
6. Panagiotakos DB, Pitsavos C, Das UN, et al. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis Diabetes Obes Metab 2007 9:5 660-668
7. Kahn R, Buse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28(9):2289-2304. (Pubitemid 41242486)
8. Catov JM, Newman AB, Roberts JM, et al. Preterm delivery and later maternal cardiovascular disease risk. Epidemiology. 2007;18(6):733-739.
9. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001;357(9273):2002-2006.
10. Catov JM, Newman AB, Roberts JM, et al. Association between infant birth weight and maternal cardiovascular risk factors in the health, aging, and body composition study. Ann Epidemiol. 2007;17(1):36-43.
11. Smith GD, Sterne J, Tynelius P, et al. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology. 2005;16(4):563-569.
12. Ehrenberg HM, Iams JD, Goldenberg RL, et al. Maternal obesity, uterine activity, and the risk of spontaneous preterm birth. Obstet Gynecol. 2009;113(1):48-52.
13. Johnson TS, Rottier KJ, Luellwitz A, et al. Maternal pre-pregnancy body mass index and delivery of a preterm infant in Missouri 1998-2000. Public Health Nurs. 2009;26(1):3-13.
14. Salihu HM, Lynch O, Alio AP, et al. Obesity subtypes and risk of spontaneous versus medically indicated preterm births in singletons and twins. Am J Epidemiol. 2008;168(1):13-20.
15. Gilbert WM, Young AL, Danielsen B. Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med. 2007;52(11):1046-1051.
16. Rey E, Couturier A. The prognosis of pregnancy in women with chronic hypertension. Am J Obstet Gynecol. 1994; 171(2):410-416.
17. Catov JM, Nohr EA, Olsen J, et al. Chronic hypertension related to risk for preterm and term small for gestational age births. Obstet Gynecol. 2008;112(2 pt 1):290-296.
18. Catov JM, Bodnar LM, Kip KE, et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol. 2007;197(6):610.e1-610.e7.
19. Catov JM, Bodnar LM, Ness RB, et al. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol. 2007;166(11):1312-1319.
20. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
21. Smith GC, Shah I, Pell JP, et al. Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health. 2007;97(1):157-162.
22. Westerway SC, Davison A, Cowell S. Ultrasonic fetal measurements: new Australian standards for the new millennium. Aust N Z J Obstet Gynaecol. 2000;40(3):297-302.
23. Blair EM, Liu Y, de Klerk NH, et al. Optimal fetal growth for the Caucasian singleton and assessment of appropriateness of fetal growth: an analysis of a total population perinatal database [electronic article]. BMC Pediatr. 2005;5(1):13.
24. Mamelle N, Cochet V, Claris O. Definition of fetal growth restriction according to constitutional growth potential. Biol Neonate. 2001;80(4):277-285.
25. Lippi G, Albiero A, Montagnana M, et al. Lipid and lipoprotein profile in physiological pregnancy. Clin Lab. 2007;53(3-4): 173-177.
26. Potter JM, Nestel PJ. The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol. 1979;133(2):165-170.
27. Ananth CV, Joseph KS, Oyelese Y, et al. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol. 2005;105(5 pt 1): 1084-1091.
28. Ananth CV, Vintzileos AM. Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med. 2006; 19(12):773-782.
29. Thomson AJ, Telfer JF, Young A, et al. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is an inflammatory process. Hum Reprod. 1999; 14(1):229-236.
30. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis. 2003;168(2):351-358.
31. Chambers JC, Fusi L, Malik IS, et al. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001; 285(12):1607-1612.
32. Khoury J, Henriksen T, Christophersen B, et al. Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial. Am J Obstet Gynecol. 2005;193(4):1292- 1301.
33. Gardosi J, Chang A, Kalyan B, et al. Customised antenatal growth charts. Lancet. 1992;339(8788):283-287.
34. Hutcheon JA, Zhang X, Cnattingius S, et al. Customised birthweight percentiles: does adjusting for maternal characteristics matter? BJOG. 2008;115(11):1397-1404.